{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:39:16Z","timestamp":1777394356553,"version":"3.51.4"},"reference-count":55,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,2,3]]},"DOI":"10.3233\/jad-160800","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T12:20:57Z","timestamp":1483705257000},"page":"1087-1099","source":"Crossref","is-referenced-by-count":27,"title":["Amylin Enhances Amyloid-\u03b2 Peptide Brain to Blood Efflux Across the Blood-Brain Barrier"],"prefix":"10.1177","volume":"56","author":[{"given":"Loqman A.","family":"Mohamed","sequence":"first","affiliation":[{"name":"Department of Basic Pharmaceutical Science, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology & Experimental Therapeutics, Psychiatry, Boston University School of Medicine, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef M.","family":"Mousa","sequence":"additional","affiliation":[{"name":"Department of Basic Pharmaceutical Science, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erming","family":"Wang","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology & Experimental Therapeutics, Psychiatry, Boston University School of Medicine, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Qiao","family":"Qiu","sequence":"additional","affiliation":[{"name":"Departments of Pharmacology & Experimental Therapeutics, Psychiatry, Boston University School of Medicine, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Kaddoumi","sequence":"additional","affiliation":[{"name":"Department of Basic Pharmaceutical Science, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160800_ref1","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1989.03430180093036","article-title":"Prevalence of Alzheimer\u2019s disease in a community population of older persons. Higher than previously reported","volume":"262","author":"Evans","year":"1989","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.3233\/JAD-160800_ref2","first-page":"S87","article-title":"Neurovascular defects and faulty amyloid-\u03b2 vascular clearance in Alzheimer\u2019s disease","volume":"33","author":"Sagare","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160800_ref3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Toward a comprehensive theory for Alzheimer\u2019s disease. Hypothesis: Alzheimer\u2019s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"924","author":"Selkoe","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-160800_ref4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.3233\/JAD-160800_ref5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1471-4892(01)00126-6","article-title":"Alzheimer\u2019s disease and the amyloid cascade hypothesis: Ten years on","volume":"2","author":"Sommer","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.3233\/JAD-160800_ref6","doi-asserted-by":"crossref","first-page":"a011452","DOI":"10.1101\/cshperspect.a011452","article-title":"Neurovascular dysfunction and faulty amyloid \u03b2-peptide clearance in Alzheimer disease","volume":"2","author":"Sagare","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-160800_ref7","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.3233\/JAD-160800_ref8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1750-3639.2007.00075.x","article-title":"MDR1-P-Glycoprotein (ABCB1) mediates transport of Alzheimer\u2019s amyloid-beta peptides\u2013implications for the mechanisms of Abeta clearance at the blood-brain barrier","volume":"17","author":"Kuhnke","year":"2007","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-160800_ref9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"L\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.3233\/JAD-160800_ref10","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160800_ref11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1042\/BST0331101","article-title":"Abeta-degrading enzymes: Modulators of Alzheimer\u2019s disease pathogenesis and targets for therapeutic intervention","volume":"33","author":"Eckman","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-160800_ref12","doi-asserted-by":"crossref","first-page":"006379","DOI":"10.1101\/cshperspect.a006379","article-title":"Proteolytic degradation of amyloid \u03b2-protein.a","volume":"2","author":"Saido","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-160800_ref13","doi-asserted-by":"crossref","unstructured":"Iliff JJ , Wang M , Liao Y , Plogg BA , Peng W , Gundersen GA , Benveniste H , Vates GE , Deane R , Goldman SA , Nagelhus EA , Nedergaard M (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 4, 147ra111.","DOI":"10.1126\/scitranslmed.3003748"},{"key":"10.3233\/JAD-160800_ref14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00005072-199810000-00001","article-title":"Pathology of cerebrospinal fluid and interstitial fluid of the CNS: Significance for Alzheimer disease, prion disorders and multiple sclerosis","volume":"57","author":"Weller","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-160800_ref15","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-160800_ref16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/cn300077c","article-title":"Role of ABC transporters in the pathogenesis of Alzheimer\u2019s disease","volume":"3","author":"Abuznait","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-160800_ref17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acschemneuro.5b00040","article-title":"Age-related decline in brain and hepatic clearance of amyloid-beta is rectified by the cholinesterase inhibitors donepezil and rivastigmine in rats","volume":"6","author":"Mohamed","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-160800_ref18","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1016\/j.fct.2011.08.004","article-title":"Induction of expression and functional activity of P-glycoprotein efflux transporter by bioactive plant natural products","volume":"49","author":"Abuznait","year":"2011","journal-title":"Food Chem Toxicol"},{"key":"10.3233\/JAD-160800_ref19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2012-120319","article-title":"Enhanced brain amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer\u2019s disease","volume":"31","author":"Qosa","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160800_ref20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer\u2019s disease: Strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-160800_ref21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-160800_ref22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.3233\/JAD-160800_ref23","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.peptides.2007.06.011","article-title":"Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat","volume":"28","author":"Olsson","year":"2007","journal-title":"Peptides"},{"key":"10.3233\/JAD-160800_ref24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MED.0b013e32835b896f","article-title":"Amylin and the regulation of appetite and adiposity: Recent advances in receptor signaling, neurobiology and pharmacology","volume":"20","author":"Roth","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.3233\/JAD-160800_ref25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1100\/tsw.2001.23","article-title":"Amylin: Localization, effects on cerebral arteries and on local cerebral blood flow in the cat","volume":"1","author":"Edvinsson","year":"2001","journal-title":"ScientificWorldJournal"},{"key":"10.3233\/JAD-160800_ref26","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1210\/en.2010-0590","article-title":"Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats","volume":"151","author":"Trevaskis","year":"2010","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-160800_ref27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.3233\/JAD-160800_ref28","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.febslet.2008.05.006","article-title":"Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures","volume":"582","author":"Lim","year":"2008","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-160800_ref29","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.M111.331181","article-title":"Amyloid \u03b2 (A\u03b2) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways","volume":"287","author":"Fu","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160800_ref30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fnagi.2014.00186","article-title":"Amylin and its analogs: A friend or foe for the treatment of Alzheimer\u2019s disease?","volume":"6","author":"Qiu","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-160800_ref31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-160800_ref32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.3233\/JAD-160800_ref33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/gps.1762","article-title":"Plasma A\u03b242 levels and depression in the elderly","volume":"22","author":"Qiu","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-160800_ref34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","article-title":"Amyloid-associated depression: A prodromal depression of Alzheimer disease?","volume":"65","author":"Sun","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-160800_ref35","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-160800_ref36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2014.01.023","article-title":"Differences in amyloid-\u03b2 clearance across mouse and human blood-brain barrier models: Kinetic analysis and mechanistic modeling","volume":"79","author":"Qosa","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-160800_ref37","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1139\/y95-144","article-title":"Differential antagonism of amylin\u2019s metabolic and vascular actions with amylin receptor antagonists","volume":"73","author":"Beaumont","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.3233\/JAD-160800_ref38","doi-asserted-by":"crossref","unstructured":"Wang E , Zhu H , Wang X , Gower A , Wallack M , Blusztajn JK , Kowall N , Qiu WQ (2016) Amylin treatment reduces neuroinflammation and ameliorates abnormal patterns of gene expression in the cerebral cortex of Alzheimer\u2019s disease mouse model. J Alzheimers Dis. doi: 10.3233\/JAD-160677.","DOI":"10.3233\/JAD-160677"},{"key":"10.3233\/JAD-160800_ref39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0169-328X(01)00179-6","article-title":"Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain","volume":"93","author":"Ueda","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.3233\/JAD-160800_ref40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1476-5381.2011.01537.x","article-title":"GLP-1R and amylin agonism in metabolic disease: Complementary mechanisms and future opportunities","volume":"166","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-160800_ref41","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1073\/pnas.86.15.5738","article-title":"Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone","volume":"86","author":"Nishi","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160800_ref42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood-brain barrier: Implication for therapies in Alzheimer\u2019s disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.3233\/JAD-160800_ref43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.3233\/JAD-160800_ref44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cmet.2015.10.012","article-title":"Hypothalamic amylin acts in concert with leptin to regulate food intake","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metab"},{"key":"10.3233\/JAD-160800_ref45","doi-asserted-by":"crossref","first-page":"2323 e2321","DOI":"10.1016\/j.neurobiolaging.2010.05.025","article-title":"LRP1 mediates bidirectional transcytosis of amyloid-\u03b2 across the blood-brain barrier","volume":"32","author":"Pflanzner","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160800_ref46","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1124\/dmd.113.052514","article-title":"In vitro investigation of amyloid-\u03b2 hepatobiliary disposition in sandwich-cultured primary rat hepatocytes","volume":"41","author":"Mohamed","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.3233\/JAD-160800_ref47","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/mol.107.036913","article-title":"Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1-40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes","volume":"72","author":"Tamaki","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.3233\/JAD-160800_ref48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.5.4.397","article-title":"On the relation of chronic interstitial pancreatitis to the islands of langerhans and to diabetes melutus","volume":"5","author":"Opie","year":"1901","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-160800_ref49","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-160800_ref50","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cell.2009.11.014","article-title":"Reduced IGF-1 signaling delays age-associated proteotoxicity in mice","volume":"139","author":"Cohen","year":"2009","journal-title":"Cell"},{"key":"10.3233\/JAD-160800_ref51","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.3233\/JAD-160800_ref52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s001250051364","article-title":"Islet amyloid polypeptide in the islets of Langerhans: Friend or foe?","volume":"43","author":"Gebre-Medhin","year":"2000","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-160800_ref53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1463-1326.2010.01201.x","article-title":"Safety of pramlintide added to mealtime insulin in patients with type 1 or type 2 diabetes: A large observational study","volume":"12","author":"Pencek","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.3233\/JAD-160800_ref54","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1021\/bi981658g","article-title":"Effects of sequential proline substitutions on amyloid formation by human amylin20-29","volume":"38","author":"Moriarty","year":"1999","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-160800_ref55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fnins.2015.00216","article-title":"Amylin at the interface between metabolic and neurodegenerative disorders","volume":"9","author":"Lutz","year":"2015","journal-title":"Front Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:03Z","timestamp":1777370583000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160800"}},"subtitle":[],"editor":[{"given":"Eva","family":"Carro","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":55,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-160800","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}